Article
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus.
Blood - 1 Oct 2000
Foster C B, Lehrnbecher T, Samuels S, Stein S, Mol F, Metcalf J A, Wyvill K, Steinberg S M, Kovacs J, Blauvelt A, Yarchoan R, Chanock S J
Abstract excerpt
Kaposi sarcoma (KS) is an angioproliferative inflammatory condition that occurs commonly in patients infected with human immunodeficiency virus (HIV). Inflammatory cytokines and growth factors promote the development of KS. Because physiologically important cytokine polymorphisms modulate host inflammatory responses, we investigated the association between KS and common regulatory polymorphisms in 5...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
